I-Enclomiphene Citrate 7599-79-3 ekhethiweyo ye-estrogen receptor antagonist
Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Umthamo wemveliso:50kg/ngenyanga
Umyalelo(MOQ):1kg
Ixesha lokukhokhela:Iintsuku zokusebenza ezi-3
Imeko yokugcina:Igcinwe kwindawo epholileyo neyomileyo, ivalwe kwaye igcinwe kude nokukhanya.
Ipakethe imathiriyeli:ibhotile, ibhotile
Ubungakanani bepakethi:I-1kg / i-vial, i-5kg / i-vial, i-10kg / i-vial, i-25kg / igubu
Ulwazi ngokhuseleko:Ayizompahla eziyingozi
Intshayelelo
I-Enclomiphene isetyenziswa ikakhulu njengonyango lwamadoda ane-testosterone ephantsi eqhubekayo ngenxa ye-hypogonadotropic hypogonadism yesibini.Kwi-secondary hypogonadotropic hypogonadism, amanqanaba aphantsi asezantsi e-testosterone abangelwa kukunganeli kwi-hypothalamic-pituitary-gonadal axis.Ngokwahlukileyo, i-hypogonadism ephambili ibangelwa yiziphene kwiimvavanyo ezibangela ukuba zingakwazi ukuvelisa inani elifunekayo le testosterone.
I-Enclomiphene, evuselela ukuveliswa kwe-testosterone engapheliyo, okwangoku akwaziwa ukuba ineziphumo ezibi eziqhelekileyo zonyango lokubuyisela i-testosterone exogenous, njengokunciphisa i-spermatogenesis okanye ukungazali.
Inkcazo (kwimigangatho yendlu)
| Izinto | Iinkcukacha |
| Imbonakalo | Okumhlophe okuqinileyo |
| Ilahleko ekomisweni | ≤0.5% |
| Intsalela ekutshisweni | ≤0.1% |
| Iintsimbi ezinzima | ≤20ppm |
| Z isomers | ≤1.0%, nge-HPLC |
| Ukungcola okupheleleyo | ≤1.0%, nge-HPLC |
| Ubunyulu | ≥99.0% yi-HPLC |
